Related Experiment Video
Updated: Mar 31, 2026

High-Resolution Three-Dimensional Imaging of the Footpad Vasculature in a Murine Hindlimb Gangrene Model
Published on: March 16, 2022
Assessing Mortality Prediction: Comparing the Effectiveness of the Fournier Gangrene Severity Index and the Uludag
Emma Berenice López Pacheco1, Hugo Fernando Narvaez Gonzalez2,3, Martha Asunción Sánchez-Rodríguez4
1General Surgery, Hospital Regional General Ignacio Zaragoza, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, MEX.
Abstract:
Background Fournier's gangrene (FG) is a fulminant necrotizing infection associated with substantial morbidity and high mortality. Early and accurate risk stratification is essential to guide clinical decision-making. The Fournier Gangrene Severity Index (FGSI) and the Uludag Fournier Gangrene Severity Index (UFGSI) are widely used prognostic tools; however, their comparative performance in Mexican populations remains insufficiently characterized. This study aimed to assess the association of FGSI and UFGSI with in-hospital mortality and to explore their comparative prognostic performance in a Mexican cohort. Methodology This retrospective cohort study was conducted at a tertiary-level public hospital in Mexico City. We included 65 adults with confirmed FG treated between July 2022 and February 2025. Clinical, demographic, and laboratory data were collected to calculate FGSI, UFGSI, and the Age-Adjusted Charlson Comorbidity Index. Survivors and non-survivors were compared using Student's t-test and chi-square tests, and associations with in-hospital mortality were evaluated using multivariate logistic regression with traditional and adjusted cutoff values. Statistical significance was defined as a p-value <0.05. Results Overall mortality was 18/65 (27.7%). Most patients were male (44/65, 67.7%), and the mean age was 59.4 ± 11 years. Non-survivors were older than survivors (64.8 ± 10 vs. 57.5 ± 11 years; p < 0.05). The most frequent etiology was proctologic origin (37/65, 56.9%). The most common comorbidity was diabetes (46/65, 70.8%), followed by systemic arterial hypertension (25/65, 38.5%). Mean index scores were higher among non-survivors than survivors for both FGSI (9.1 ± 4 vs. 5.8 ± 3; p = 0.002) and UFGSI (12.6 ± 5 vs. 8.4 ± 4; p = 0.001). Using traditional cutoff points, multivariate logistic regression demonstrated statistically significant associations with mortality for FGSI (odds ratio (OR) = 3.70; 95% confidence interval (CI) = 1.01-13.55; p = 0.048) and UFGSI (OR = 4.70; 95% CI = 1.26-17.44; p = 0.021). Conclusions FGSI and UFGSI were both associated with in-hospital mortality in FG. In this cohort, UFGSI showed a stronger association with in-hospital mortality using traditional cutoff values. Larger prospective studies are warranted to validate adjusted cutoff points across diverse clinical settings.
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Comparing the Survival Analysis of Two or More Groups
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...

